Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
NCT04024306 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2023-07-19
Summary
The aim of the study is to determine the prevalence of steroid-induced diabetes mellitus (SDM) among systemic lupus erythematosus (SLE) patients and identify and assess the associated risk factors .
Conditions
- System; Lupus Erythematosus
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2024-04-01
- Completion
- 2024-04-20
Countries
- Egypt
Study Locations
More Related Trials
-
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
NCT06610409 ·Status: NOT_YET_RECRUITING
-
Insulin Resistance and Atherosclerosis in Women With Lupus
NCT00544102 ·Status: COMPLETED
-
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
NCT06151990 ·Status: RECRUITING
-
Accuracy, Feasibility and Acceptance of CGM Lupus
NCT03296995 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment
NCT02330250 ·Status: COMPLETED ·Phase: NA
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
Effect of Gender on Clinical Presentation of SLE ِAt Assiut University Hospitals
NCT04234633 ·Status: UNKNOWN
-
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
NCT06718283 ·Status: RECRUITING
-
Haematological Indices in Systemic Lupus Erythematosus
NCT04110184 ·Status: UNKNOWN
-
SLE Vasculitis In Egyptian Patients
NCT04386889 ·Status: UNKNOWN ·Phase: NA
-
Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients
NCT02321709 ·Status: COMPLETED ·Phase: PHASE1
-
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
NCT05964751 ·Status: UNKNOWN
-
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
NCT06631404 ·Status: RECRUITING
-
WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)
NCT01616472 ·Status: COMPLETED
-
Safety of Administering Isoniazid to SLE Patients to Prevent TB
NCT06618573 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Flow Mediated Dilation in Association With Hyperuricemia
NCT05342285 ·Status: UNKNOWN
-
Urinary Congophilia As an Indicator of Activity of Lupus Nephritis
NCT06654024 ·Status: NOT_YET_RECRUITING
-
Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus
NCT04970199 ·Status: COMPLETED ·Phase: NA
-
Comparison between2 Drugs in Lupus Nephritis
NCT04424602 ·Status: COMPLETED ·Phase: PHASE4
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice
NCT04558203 ·Status: COMPLETED
-
Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus
NCT04532541 ·Status: RECRUITING
-
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
NCT06313151 ·Status: RECRUITING